Treace Medical Concepts, Inc. – NASDAQ:TMCI

Add to watchlist

$7.04

+0.05

+0.86%

Market closed

Open in about 13 hours

-14.04%

month

-14.04%

quarter

-45.72%

year

Market Cap	431.09M
Enterprise value	1.51B

P/E	-31.69
EV/Sales	10.64
EV/EBITDA	-40.46
Price/Sales	10.30
Price/Book	24.14
PEG ratio	0.49
EPS	-0.88

Revenue	196.03M
EBITDA	-49.78M
Income	-54.74M
Revenue Q/Q	21.12%
Revenue Y/Y	26.48%

Profit margin	-30.19%
Oper. margin	-24.57%
Gross margin	80.6%
EBIT margin	-24.57%
EBITDA margin	-25.4%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Treace Medical Concepts, Inc. (NASDAQ:TMCI): Profit margin
Jun 2023	41.95M	-12.27M	-29.25%
Sep 2023	40.75M	-17.52M	-42.99%
Dec 2023	62.21M	-6.28M	-10.1%
Mar 2024	51.10M	-18.67M	-36.54%

Treace Medical Concepts Financials Estimate

Q Y

Treace Medical Concepts, Inc. (NASDAQ:TMCI): Analyst Estimates
Sep 2025	58.36M	-15.80M	-27.08%
Oct 2025	49.79M	-14.96M	-30.05%
Dec 2025	75.46M	-5.21M	-6.9%
Mar 2026	67.83M	-20.78M	-30.63%

Analysts Price target
Financials & Ratios estimates

Treace Medical Concepts, Inc. (NASDAQ:TMCI): Earnings per share (EPS)
2024-02-27	-0.09	-0.1

Treace Medical Concepts, Inc. (NASDAQ:TMCI): Debt to assets
Jun 2023	249643000	99.68M	39.93%
Sep 2023	240360000	102.5M	42.64%
Dec 2023	251907000	113.96M	45.24%
Mar 2024	242726000	116.33M	47.93%

Treace Medical Concepts, Inc. (NASDAQ:TMCI): Cash Flow
Jun 2023	-8.33M	-10.42M	1.18M
Sep 2023	-9.51M	4.59M	159K
Dec 2023	532K	5.00M	165K
Mar 2024	-7.22M	3.75M	-185K

Treace Medical Concepts alternative data

Treace Medical Concepts
Employees

Treace Medical Concepts, Inc. (NASDAQ:TMCI): Employee count
Aug 2023	423
Sep 2023	423
Oct 2023	423
Nov 2023	423
Dec 2023	423
Jan 2024	423
Feb 2024	423
Mar 2024	516
Apr 2024	516
May 2024	516
Jun 2024	516
Jul 2024	516

Treace Medical Concepts
Hedge Funds Holdings Q3 2022

36.26% -5.06%

of TMCI is owned by hedge funds

79 -2

hedge funds hold TMCI stock

20.05M -2.59M

shares is hold by hedge funds

TMCI hedge funds holdings changes

Treace Medical Concepts
Insider Trading

Treace Medical Concepts, Inc. (NASDAQ:TMCI): Insider trades (number of shares)
Period	Buy	Sel
May 2024	881258	0
Jun 2024	45000	0
Aug 2024	169000	0
Sep 2024	50000	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	16 Sep 2024	TREACE JOHN T. director, 10 percent owner, officer: Chief .. director, 10 percent owner, off..	Common Stock	50,000	$5.31	$265,650
Option	12 Sep 2024	SCANLAN SEAN F. officer: Chief Innovation Officer officer: Chief Innovation Officer	Common Stock	33,750	$0.1	$3,274
Option	12 Sep 2024	SCANLAN SEAN F. officer: Chief Innovation Officer officer: Chief Innovation Officer	Stock Option (Right to Buy)	33,750	$0.1	$3,274
Purchase	15 Aug 2024	TREACE JAMES T director director	Common Stock	84,000	$5.97	$501,060
Purchase	14 Aug 2024	TREACE JOHN T. director, 10 percent owner, officer: Chief .. director, 10 percent owner, off..	Common Stock	85,000	$6	$510,340
Purchase	11 Jun 2024	TREACE JOHN T. director, 10 percent owner, officer: Chief .. director, 10 percent owner, off..	Common Stock	45,000	$5.88	$264,600
Purchase	31 May 2024	TREACE JAMES T director director	Common Stock	25,000	$6.05	$151,325
Purchase	29 May 2024	TREACE JAMES T director director	Common Stock	25,000	$5.2	$130,075
Purchase	28 May 2024	TREACE JAMES T director director	Common Stock	50,000	$5.07	$253,500
Purchase	24 May 2024	MOTT RICHARD W director director	Common Stock	18,000	$5.2	$93,510

TMCI insider trading transactions

Treace Medical Concepts
Patents

Status	Patent	Filling date	Issue date
Grant	Grant Utility: Bone positioning guide Filling date: 29 Nov 2021 Issue date: 6 Sep 2022	29 Nov 2021	6 Sep 2022
Grant	Grant Utility: Intra-osseous plate system and method Filling date: 18 May 2020 Issue date: 30 Aug 2022	18 May 2020	30 Aug 2022
Application	Application SYSTEM AND TECHNIQUE FOR METATARSAL REALIGNMENT WITH REDUCED INCISION LENGTH Filling date: 17 Feb 2022 Issue date: 18 Aug 2022	17 Feb 2022	18 Aug 2022
Grant	Grant Utility: Tarsal-metatarsal joint procedure utilizing fulcrum Filling date: 21 Jun 2019 Issue date: 16 Aug 2022	21 Jun 2019	16 Aug 2022
Application	Application CONTOURED BONE PLATE WITH LOCKING SCREW FOR BONE COMPRESSION, PARTICULARLY ACROSS A TARSOMETATARSAL JOINT Filling date: 17 Jan 2022 Issue date: 21 Jul 2022	17 Jan 2022	21 Jul 2022
Grant	Grant Utility: Techniques for performing an osteotomy procedure on bone to correct a bone misalignment Filling date: 9 Mar 2020 Issue date: 21 Jun 2022	9 Mar 2020	21 Jun 2022
Grant	Grant Utility: Bone plating kit for foot and ankle applications Filling date: 18 Feb 2019 Issue date: 31 May 2022	18 Feb 2019	31 May 2022
Application	Application BONE POSITIONING AND PREPARING GUIDE SYSTEMS AND METHODS Filling date: 3 Jan 2022 Issue date: 21 Apr 2022	3 Jan 2022	21 Apr 2022
Grant	Grant Utility: Tarsal-metatarsal joint procedure utilizing fulcrum Filling date: 8 Jul 2019 Issue date: 22 Mar 2022	8 Jul 2019	22 Mar 2022
Application	Application BONE POSITIONING GUIDE Filling date: 29 Nov 2021 Issue date: 17 Mar 2022	29 Nov 2021	17 Mar 2022

TMCI patents

Treace Medical Concepts
Earnings Call Transcripts

Quarter	Transcript
Q1 2024 11 May 2024	Q1 2024 Earnings Call Transcript
Q4 2023 28 Feb 2024	Q4 2023 Earnings Call Transcript
Q3 2023 11 Nov 2023	Q3 2023 Earnings Call Transcript
Q2 2023 12 Aug 2023	Q2 2023 Earnings Call Transcript

TMCI earnings call transcripts

Treace Medical Concepts
Executives

Insider	Age	Compensation
Mr. John T. Treace (1972) Chief Executive Officer, Founder & Director	53	$370,860
Mr. Jaime A. Frias (1962) Chief Legal Officer & Sec.	63	$271,040
Mr. Mark L. Hair CPA (1970) Chief Financial Officer	55	$104,410

Treace Medical Concepts
Latest News

Monday, 30 December 2024
08:15	Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure	globenewswire.com
Sunday, 29 December 2024
11:30	The Schall Law Firm Urges Shareholders With Losses To Join An Inquiry Into Treace Medical Concepts Inc For Securities Fraud	accesswire.com
Saturday, 28 December 2024
12:00	Treace Medical Concepts, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Invited To Contact The Schall Law Firm	accesswire.com
Thursday, 26 December 2024
11:30	Treace Medical Concepts, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Encouraged To Contact The Schall Law Firm	accesswire.com
Tuesday, 24 December 2024
10:45	The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Treace Medical Concepts Inc For Securities Fraud	accesswire.com
Monday, 23 December 2024
11:00	Treace Medical Concepts, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law Firm	accesswire.com
Saturday, 21 December 2024
12:30	The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Treace Medical Concepts Inc For Securities Fraud	accesswire.com
Friday, 20 December 2024
14:15	Treace Medical Concepts, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law Firm	accesswire.com
Thursday, 19 December 2024
10:30	The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Treace Medical Concepts Inc For Securities Fraud	accesswire.com
Wednesday, 18 December 2024
13:45	Treace Medical Concepts Inc. Is Being Investigated For Securities Law Violations And Investors With Losses Are Invited To Contact The Schall Law Firm	accesswire.com
Tuesday, 17 December 2024
13:30	The Schall Law Firm Urges Stockholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud	accesswire.com
Monday, 16 December 2024
13:15	Treace Medical Concepts Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law Firm	accesswire.com
08:30	Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant	globenewswire.com
Sunday, 15 December 2024
17:15	The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud	accesswire.com
Saturday, 14 December 2024
13:45	Treace Medical Concepts Inc Is Being Investigated For Securities Law Violations And Investors With Losses Are Invited To Contact The Schall Law Firm	accesswire.com
Friday, 13 December 2024
17:15	The Schall Law Firm Encourages Stockholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud	accesswire.com
Thursday, 12 December 2024
13:45	Treace Medical Concepts Inc Is Being Investigated For Securities Law Violations And Affected Investors Are Invited To Contact The Schall Law Firm	accesswire.com
Wednesday, 11 December 2024
17:45	The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud	accesswire.com
10:49	TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm	prnewswire.com
Tuesday, 10 December 2024
17:15	Treace Medical Concepts Inc Is Being Investigated For Securities Law Violations And Affected Investors Are Invited To Contact The Schall Law Firm	accesswire.com
Monday, 9 December 2024
17:45	The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud	accesswire.com
Sunday, 8 December 2024
18:30	Treace Medical Concepts Inc Is Being Investigated For Securities Related Infractions And Affected Investors Are Invited To Contact The Schall Law Firm	accesswire.com
Saturday, 7 December 2024
18:20	The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud	accesswire.com
Friday, 6 December 2024
11:45	Treace Medical Concepts Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law Firm	accesswire.com
Thursday, 5 December 2024
10:30	The Schall Law Firm Encourages Stockholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud	accesswire.com
Wednesday, 4 December 2024
16:30	Treace Medical Concepts Inc Is Being Investigated For Possible Securities Law Violations And Affected Investors Are Invited To Contact The Schall Law Firm	accesswire.com
16:15	Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities	globenewswire.com
Monday, 2 December 2024
16:15	Treace Appoints Guy Guglielmino as Chief Commercial Officer	globenewswire.com
Sunday, 1 December 2024
14:45	The Schall Law Firm Wants Shareholders To Take Part In An Inquiry Into Treace Medical Concepts Inc's Securities Law Violations	accesswire.com
Saturday, 30 November 2024
14:00	Treace Medical Concepts, Inc. Is Being Investigated For Possible Securities Fraud And Investors With Losses Are Invited To Join The Schall Law Firm	accesswire.com

Frequently Asked Questions (FAQ)

What's the price of Treace Medical Concepts stock today?

One share of Treace Medical Concepts stock can currently be purchased for approximately $7.04.
When is Treace Medical Concepts's next earnings date?

Unfortunately, Treace Medical Concepts's (TMCI) next earnings date is currently unknown.
Does Treace Medical Concepts pay dividends?

No, Treace Medical Concepts does not pay dividends.
How much money does Treace Medical Concepts make?

Treace Medical Concepts has a market capitalization of 431.09M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 31.92% to 187.12M US dollars. Treace Medical Concepts made a loss 49.53M US dollars in net income (profit) last year or -$0.1 on an earnings per share basis.
What is Treace Medical Concepts's stock symbol?

Treace Medical Concepts, Inc. is traded on the NASDAQ under the ticker symbol "TMCI".
What is Treace Medical Concepts's primary industry?

Company operates in the Healthcare sector and Medical - Devices industry.
How do i buy shares of Treace Medical Concepts?

Shares of Treace Medical Concepts can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Treace Medical Concepts's key executives?
Treace Medical Concepts's management team includes the following people:
- Mr. John T. Treace Chief Executive Officer, Founder & Director(age: 53, pay: $370,860)
- Mr. Jaime A. Frias Chief Legal Officer & Sec.(age: 63, pay: $271,040)
- Mr. Mark L. Hair CPA Chief Financial Officer(age: 55, pay: $104,410)
Is Treace Medical Concepts founder-led company?

Yes, Treace Medical Concepts is a company led by its founder Mr. John T. Treace.
How many employees does Treace Medical Concepts have?

As Jul 2024, Treace Medical Concepts employs 516 workers.
When Treace Medical Concepts went public?

Treace Medical Concepts, Inc. is publicly traded company for more then 4 years since IPO on 23 Apr 2021.
What is Treace Medical Concepts's official website?

The official website for Treace Medical Concepts is treace.com.
Where are Treace Medical Concepts's headquarters?

Treace Medical Concepts is headquartered at 203 Fort Wade Road, Ponte Vedra, FL.
How can i contact Treace Medical Concepts?

Treace Medical Concepts's mailing address is 203 Fort Wade Road, Ponte Vedra, FL and company can be reached via phone at +90 43735940.

Treace Medical Concepts, Inc.

treace.com

Exchange:

NASDAQ

Full time employees:

516

Industry:

Medical - Devices

Sector:

Healthcare

Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.

+90 43735940

203 Fort Wade Road
Ponte Vedra, FL 32081

CIK: 0001630627
ISIN: US89455T1097
CUSIP: 89455T109